Novavax, Inc. (NVAX) vs Novocure Ltd (NVCR)

A side-by-side comparison of Novavax, Inc. and Novocure Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NVAX vs NVCR

growth of $100 · dividends reinvested · last 10y
NVAX -68.6% (-10.9%/yr)NVCR +73.5% (+5.7%/yr)NVCR compounded faster over this window
Log scale — wide-divergence pair
1101001k10kStart $10020182020202220242026$31$174
NVAX NVCR

NVAX vs NVCR: by the numbers

  • •NVAX is the larger company ($1.83B vs $1.76B market cap).
  • •Both run net losses; NVCR's is the smaller (-21.25% vs -59.87% net margin).
  • •NVAX grew revenue faster over the past five years (118.86% vs 5.12% CAGR).

Metrics side by side

Valuation

MetricNVAXNVCR
P/S ratio4.422.52
P/B ratioN/A5.22

Profitability

MetricNVAXNVCR
Gross margin93.67%76.13%
Operating margin50.14%-22.08%
Net margin-59.87%-21.25%
ROEN/A-43.94%
ROIC-36.37%-26.88%

Growth (annualized)

MetricNVAXNVCR
Revenue CAGR (5Y)118.86%5.12%
Total return CAGR (5Y)-40.61%-32.71%

Frequently asked

Which has grown faster, NVAX or NVCR?
Over the past five years, NVAX grew revenue faster — NVAX at a 118.86% CAGR versus NVCR at 5.12%.
How have NVAX and NVCR total returns compared?
Over the past 10 years, NVAX delivered -10.98% and NVCR delivered 5.67% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.